Yahoo Web Search

Search results

1. • Amgen Inc. (NASDAQ:AMGN) Holdings Cut by Panagora Asset Management Inc.

     ETF DAILY NEWS· 1 day ago

     Panagora Asset Management Inc. decreased its position in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 9.1% in the fourth quarter, according to the company in its most recent disclosure ...

2. • 

     It Took Me Years to Find the Right Psoriatic Arthritis Medication

     Verywell Health via Yahoo News· 7 days ago

     After being diagnosed with psoriatic arthritis in 2016, it took LB Herbert years to find a psoriatic...

3. • Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides...

     WKRN Nashville· 6 days ago

     Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflammation and immunology (I&I) biological products and on providing ...

4. • 

     7 Biotech Stocks That Could Breathe New Life Into Your Portfolio

     InvestorPlace· 17 hours ago

     Fundamentally, one of the biggest advantages of biotech stocks to buy centers on the underlying...

5. • AbbVie Inc. (NYSE:ABBV) to Post Q2 2024 Earnings of $3.01 Per Share, Zacks Research Forecasts

     ETF DAILY NEWS· 5 days ago

     AbbVie Inc. (NYSE:ABBV – Free Report) – Analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of AbbVie in a research report issued to clients and investors on Tuesday ...

6. • 

     Earnings call: Arcutis Biotherapeutics reports strong Q1 2024 growth

     Investing.com· 6 days ago

     Arcutis expressed confidence in its growth trajectory, citing improvements in gross-to-net (GTN)...

7. • 

     Why Is My Scalp Flaky? Exploring The Causes Of Dandruff And How It’s Treated

     IFLScience· 3 days ago

     Dandruff is a harmless – if irritating – condition that usually affects the skin of the scalp,...

8. • AbbVie (NYSE:ABBV) Now Covered by Cantor Fitzgerald

     ETF DAILY NEWS· 2 days ago

     Cantor Fitzgerald assumed coverage on shares of AbbVie (NYSE:ABBV – Get Free Report) in a research note issued to investors on Friday, MarketBeat.com reports. Cantor Fitzgerald’s price objective ...

9. • 

     Critics Say FDA's Use of Surrogate Markers Falling Short

     Medscape· 4 days ago

     As the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...

10. • Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)

      ETF DAILY NEWS· 4 days ago

      AbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on Tuesday, May 14th. Zacks Research analyst ...